Inari Medical, Inc. (NARI)
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Investigation
09/24/2021
Initial Lawsuit
09/24/2021
Lawsuit Progression
12/13/2021
Investigation regarding AppHarvest’s statements about its labor force, operational headwinds and production ramp-up challenges.
08/11/2021
AppHarvest announces its Q2 2021 financial results, its second quarter as a publicly traded company. The company reports a net loss of $32 million as compared to a net loss of $1.6 million for Q2 2020.
“Second quarter 2021 results were adversely impacted by operational headwinds with the ramp up to full production at the company’s first CEA facility, including labor and productivity challenges related to the training and development of the new workforce and historically low market prices for tomatoes during the second quarter of 2021 based on USDA reports. Labor and productivity challenges resulted in lower net sales due to lower overall No. 1-grade production yields, including the impact of higher distribution and shipping fees.”
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$8.51 | $11.97 | $-3.46 | -28.91% |
Plaintiff brings this securities class action on behalf of persons and entities that purchased or otherwise acquired AppHarvest securities between May 17, 2021 and August 10, 2021, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(1) that AppHarvest lacked sufficient training for its recently expanded labor force;
(2) that, as a result, the company could not produce Grade No. 1 tomatoes consistently;
(3) that, as a result, the company’s financial results would be adversely impacted; and
(4) that, as a result of the foregoing, defendants’ positive statements about the company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
12/13/2021
The court issued an order appointing the lead plaintiff and lead counsel.
03/02/2022
Lead Plaintiff brings this action pursuant to 15 U.S.C. §§78j(b) and 78t(a) (Section 10(b) and Section 20(a), respectively) of the Securities Exchange Act of 1934 and 17 C.F.R. § 240.10b-5 (Rule 10b-5) promulgated thereunder by the SEC, on behalf of himself and all persons and entities other than defendants (defined in the complaint) who purchased or otherwise acquired securities of AppHarvest, Inc., between February 1, 2021 and August 10, 2021, inclusive, and were injured thereby.
Additional amended complaints have been filed, please refer to the last filed amended complaint for up-to-date information.
07/25/2022
Lead Plaintiff Alan Narzissenfeld brings this action pursuant to 15 U.S.C. §§ 78j(b) and 78t(a) of the Securities Exchange Act of 1934 and 17 C.F.R. § 240.10b-5promulgated thereunder by the SEC, on behalf of himself and all persons and entities other than Defendants (defined in the 2nd amended complaint) who purchased or otherwise acquired securities of AppHarvest, Inc. (APPH), between February 1, 2021 and August 10, 2021, inclusive, and were injured thereby.
Operative complaint
05/02/2022
A motion to dismiss was filed with the court.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.